305 related articles for article (PubMed ID: 15968462)
41. Arginine-rich cell-penetrating peptides.
Schmidt N; Mishra A; Lai GH; Wong GC
FEBS Lett; 2010 May; 584(9):1806-13. PubMed ID: 19925791
[TBL] [Abstract][Full Text] [Related]
42. Passage of cell-penetrating peptides across a human epithelial cell layer in vitro.
Lindgren ME; Hällbrink MM; Elmquist AM; Langel U
Biochem J; 2004 Jan; 377(Pt 1):69-76. PubMed ID: 12968950
[TBL] [Abstract][Full Text] [Related]
43. Cell-penetrating properties of the transactivator of transcription and polyarginine (R9) peptides, their conjugative effect on nanoparticles and the prospect of conjugation with arsenic trioxide.
Kanwar JR; Gibbons J; Verma AK; Kanwar RK
Anticancer Drugs; 2012 Jun; 23(5):471-82. PubMed ID: 22241171
[TBL] [Abstract][Full Text] [Related]
44. Cell-penetrating peptides do not cross mitochondrial membranes even when conjugated to a lipophilic cation: evidence against direct passage through phospholipid bilayers.
Ross MF; Filipovska A; Smith RA; Gait MJ; Murphy MP
Biochem J; 2004 Nov; 383(Pt. 3):457-68. PubMed ID: 15270716
[TBL] [Abstract][Full Text] [Related]
45. Alternative mechanisms for the interaction of the cell-penetrating peptides penetratin and the TAT peptide with lipid bilayers.
Yesylevskyy S; Marrink SJ; Mark AE
Biophys J; 2009 Jul; 97(1):40-9. PubMed ID: 19580742
[TBL] [Abstract][Full Text] [Related]
46. Photodamage of lipid bilayers by irradiation of a fluorescently labeled cell-penetrating peptide.
Meerovich I; Muthukrishnan N; Johnson GA; Erazo-Oliveras A; Pellois JP
Biochim Biophys Acta; 2014 Jan; 1840(1):507-15. PubMed ID: 24135456
[TBL] [Abstract][Full Text] [Related]
47. Peptide-glycosaminoglycan cluster formation involving cell penetrating peptides.
Rullo A; Qian J; Nitz M
Biopolymers; 2011 Oct; 95(10):722-31. PubMed ID: 21538329
[TBL] [Abstract][Full Text] [Related]
48. Intracellular cargo delivery using tat peptide and derivatives.
Zhao M; Weissleder R
Med Res Rev; 2004 Jan; 24(1):1-12. PubMed ID: 14595670
[TBL] [Abstract][Full Text] [Related]
49. Organelle-targeted delivery of biological macromolecules using the protein transduction domain: potential applications for Peptide aptamer delivery into the nucleus.
Yoshikawa T; Sugita T; Mukai Y; Yamanada N; Nagano K; Nabeshi H; Yoshioka Y; Nakagawa S; Abe Y; Kamada H; Tsunoda S; Tsutsumi Y
J Mol Biol; 2008 Jul; 380(5):777-82. PubMed ID: 18571668
[TBL] [Abstract][Full Text] [Related]
50. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles.
Magzoub M; Kilk K; Eriksson LE; Langel U; Gräslund A
Biochim Biophys Acta; 2001 May; 1512(1):77-89. PubMed ID: 11334626
[TBL] [Abstract][Full Text] [Related]
51. A TAT-streptavidin fusion protein directs uptake of biotinylated cargo into mammalian cells.
Albarran B; To R; Stayton PS
Protein Eng Des Sel; 2005 Mar; 18(3):147-52. PubMed ID: 15820981
[TBL] [Abstract][Full Text] [Related]
52. Cell-penetrating peptides.
Lindgren M; Hällbrink M; Prochiantz A; Langel U
Trends Pharmacol Sci; 2000 Mar; 21(3):99-103. PubMed ID: 10689363
[TBL] [Abstract][Full Text] [Related]
53. Cellular translocation of a γ-AApeptide mimetic of Tat peptide.
Niu Y; Bai G; Wu H; Wang RE; Qiao Q; Padhee S; Buzzeo R; Cao C; Cai J
Mol Pharm; 2012 May; 9(5):1529-34. PubMed ID: 22413929
[TBL] [Abstract][Full Text] [Related]
54. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells.
Thorén PE; Persson D; Isakson P; Goksör M; Onfelt A; Nordén B
Biochem Biophys Res Commun; 2003 Jul; 307(1):100-7. PubMed ID: 12849987
[TBL] [Abstract][Full Text] [Related]
55. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics.
Heitz F; Morris MC; Divita G
Br J Pharmacol; 2009 May; 157(2):195-206. PubMed ID: 19309362
[TBL] [Abstract][Full Text] [Related]
56. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo.
Suhorutsenko J; Oskolkov N; Arukuusk P; Kurrikoff K; Eriste E; Copolovici DM; Langel U
Bioconjug Chem; 2011 Nov; 22(11):2255-62. PubMed ID: 21978260
[TBL] [Abstract][Full Text] [Related]
57. A peptide carrier for the delivery of biologically active proteins into mammalian cells.
Morris MC; Depollier J; Mery J; Heitz F; Divita G
Nat Biotechnol; 2001 Dec; 19(12):1173-6. PubMed ID: 11731788
[TBL] [Abstract][Full Text] [Related]
58. Tat-mediated delivery of heterologous proteins into cells.
Fawell S; Seery J; Daikh Y; Moore C; Chen LL; Pepinsky B; Barsoum J
Proc Natl Acad Sci U S A; 1994 Jan; 91(2):664-8. PubMed ID: 8290579
[TBL] [Abstract][Full Text] [Related]
59. Tat peptide-mediated cellular delivery: back to basics.
Brooks H; Lebleu B; Vivès E
Adv Drug Deliv Rev; 2005 Feb; 57(4):559-77. PubMed ID: 15722164
[TBL] [Abstract][Full Text] [Related]
60. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore.
Trofimenko E; Grasso G; Heulot M; Chevalier N; Deriu MA; Dubuis G; Arribat Y; Serulla M; Michel S; Vantomme G; Ory F; Dam LC; Puyal J; Amati F; Lüthi A; Danani A; Widmann C
Elife; 2021 Oct; 10():. PubMed ID: 34713805
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
